Boston Bio

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE109B01019
  • NSEID:
  • BSEID: 531458
INR
7.27
0.00 (0.00%)
BSENSE

Dec 04

BSE+NSE Vol: 3.45 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Mar'18
Mar'17
Mar'16
Mar'15
Mar'14
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 0.00%

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2025 is -292.86%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -292.86%

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Boston Bio With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
0.19
0.35
-0.16
-45.71%
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.19
0.35
-0.16
-45.71%
Raw Material Cost
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.34
-0.34
-100.00%
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
0.00
0.19
-0.19
-100.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
0.74
0.21
0.53
252.38%
Total Expenditure (Excl Depreciation)
0.74
0.74
0.00
Operating Profit (PBDIT) excl Other Income
-0.55
-0.39
-0.16
-41.03%
Other Income
0.00
0.34
-0.34
-100.00%
Operating Profit (PBDIT)
-0.55
-0.05
-0.50
-1,000.00%
Interest
0.00
0.01
-0.01
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
-0.55
-0.06
-0.49
-816.67%
Depreciation
0.00
0.01
-0.01
-100.00%
Profit Before Tax
-0.55
-0.06
-0.49
-816.67%
Tax
0.00
0.01
-0.01
-100.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-0.55
-0.07
-0.48
-685.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-0.55
-0.07
-0.48
-685.71%
Equity Capital
7.00
11.95
-4.95
-41.42%
Face Value
10.00
10.00
0.00
Reserves
-1.10
0.56
-1.66
-296.43%
Earnings per share (EPS)
-0.79
-0.06
-0.73
-1,216.67%
Diluted Earnings per share
-0.78
-0.06
-0.72
-1,200.00%
Operating Profit Margin (Excl OI)
-289.47%
-111.43%
0.00
-178.04%
Gross Profit Margin
-289.47%
-17.14%
0.00
-272.33%
PAT Margin
-289.47%
-20.00%
0.00
-269.47%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 0.19 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.00%

Annual - Standalone Net Profit
Standalone Net Profit -0.55 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -292.86%

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.55 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -292.86%

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -289.47%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024